article thumbnail

Curio Digital Therapeutics: Pivotal Trial for Postpartum Depression Digital Therapeutic Meets Efficacy Endpoints

Digital Health Global

SuMMER (NCT05958095), a study executed by HITLAB, a renowned healthcare innovation and research organization, is a randomized clinical trial of MamaLift Plus, a digital therapeutic for women experiencing perinatal mood disturbances.

article thumbnail

HIC Set to Create Innovation Hub at NHS ConfedExpo 2024

Healthcare Innovation Consortium

The stand is set to showcase a diverse range of digital health solutions designed to improve patient care, streamline operations, and drive efficiencies across the healthcare system. Meet The Innovators On Our Stand! NHS colleagues and suppliers are both eligible.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

HIC Awarded Two NHS SBS Frameworks

Healthcare Innovation Consortium

HIC Awarded Two NHS SBS Frameworks for Consultancy and Advisory Services Healthcare Innovation Consortium has been named as a supplier on two NHS Shared Business Services ’ framework agreements – Consultancy and Advisory Services for Health and Digital Health Advisory Services.

article thumbnail

HIC Joins UK HealthTech Pioneers on ABHI Trade Visit to Texas

Healthcare Innovation Consortium

HIC Joins UK HealthTech Pioneers on ABHI Trade Visit to Texas Healthcare Innovation Consortium is excited to be among the delegate of UK HealthTech innovators heading to Texas this week, as part of the first trade visit of 2023 organised by the Association of British HealthTech Industries (ABHI)’s for its new class of ABHI US Accelerator companies.

article thumbnail

Credo Health Announces Oversubscribed $5.25 Million Series Seed Funding

Healthcare IT Today

“It’s clear that value-based care providers need a technology partner that not only empowers providers to deliver the highest quality patient care but also one that ensures accurate, up-to-date risk adjustment and quality information that meets the latest regulatory guidelines.” Originally announced January 4th, 2024

EHR 99
article thumbnail

Six companies tackling AMR embark on Innovation Programme  

Healthcare Innovation Consortium

Six companies tackling AMR join Innovation Programme Six developers of solutions to address antimicrobial resistance (AMR) have been selected to take part in Healthcare Innovation Consortium’s AMR Innovation Programme , starting today. For more information on each of the Cohort click here.

article thumbnail

UK and Middle East healthcare organisations launch AMR Innovation Programme  

Healthcare Innovation Consortium

A new AMR Innovation Programme launched at Global Health today (30 October), opened by Professor Steve Field, UK Special Healthcare Representative to Saudi Arabia. Professor Field raised the need for new health technologies to meet the UK government’s priority to contain and control antimicrobial resistance (AMR) by 2040.